
Nutri-tion Graft-ed within therapy.
– We are Rebuilding Patient Nutrition Across the Gastrointestinal Care Continuum
Every year, millions of patients battling gastrointestinal disorders face a challenge that often goes unnoticed: their bodies can no longer absorb the nutrition they desperately need to heal, recover, and live with dignity.
NutriGraft is a Switzerland-based emerging nutrition company developing personalized, disease-specific nutritional solutions for patients with gastrointestinal disorders. We address one of the healthcare’s largest unmet needs: effective nutritional support for patients affected by malnutrition, malabsorption and impaired gastrointestinal function.
Provisional Patent Application is being filed
NutriGraft combines clinically grounded formulation design with a convenient format to make targeted nutrition easier to use, easier to tolerate and easier to integrate into daily care.
Our modular solution is being developed around three core clinical needs:
- Absorption — supporting patients with pancreatic and GI absorption challenges
- Adaptation — supporting patients with short bowel syndrome and intestinal adaptation needs
- Recovery — supporting colorectal cancer recovery, rehabilitation and survivorship nutrition
By moving beyond generic supplementation, NutriGraft aims to deliver nutrition that is specific to the patient’s condition, treatment phase and care pathway.
NutriGraft’s Value to Key Clients
Dietician, Nutritionist, Clinicians
1. Clinical Credibility
2. Evidence-based Formulations
3. Condition Specificity
4. Usability/adherence
5. Measurable Patient Outcome
6. Scalable Implementation
Patients, Care-givers, Gut-health seekers
1. Ease of use/Convenience
2. Feeling that the products is made for their exact need
3. Support for strength, recovery and well-being
4. Trust & Safety
NutriGraft: The right nutrition. For the right patient. At the right time.
“There are many things to consider around how to optimally eat and hydrate during cancer treatment. Some cancer treatments can lead to malnutrition or cause side effects – such as anorexia and cachexia – that affect nutrition.”
Colorectal Cancer Alliance, USA
“Even when I do everything I’m told – enzymes, supplements, small meals, diet changes – I’m still fighting to meet my nutrition needs. Chemo days, the nausea makes every bite feel like another treatment.”
Pancreatic Cancer Action Network, USA

NutriGraft is to be incorporated soon and is currently operated under the leadership of Inferre Healthcare
NutriGraft is currently seeking conversations with:
- Dieticians, Nutrition Specialist, Patient Advocacy Groups and Clinical Experts in gastroenterology
- CDMO and formulation partners with EU-GMP manufacturing capabilities
- Food-as-medicine, nutraceutical and medical nutrition industry partners
- Early-stage investors and strategic advisors, partners
If you are interested in helping bring condition-specific nutrition closer to patients and clinicians, we would welcome a conversation.
FOUNDERS

Dr. Yury Makhankov
MD, Ph.D, Medical Affair
LinkedIn
Yury, Co-Founder and Chief Scientific Officer of NutriGraft, drives clinical and medical strategy to accelerate access, strengthen evidence, and improve patient outcomes globally.

Santoro Di Franco
Professional MSc in Foreign Trade, BA in International Freight Forwarding & Logistics, Former CEO, Startup Mentor & Coach
LinkedIn
Santoro, Co-Founder and Chief Executive Officer of NutriGraft, specializes in building and scaling strategic partnerships in health innovation, connecting stakeholders to drive execution-focused, impactful collaborations.

Dr. Avisek Ghose
Ph.D Biophysics, Healthcare Market Access
LinkedIn
Avisek, Co-Founder and Chief Operating Officer of NutriGraft, drives market access and commercialization strategies to help innovative healthcare solutions reach patients faster and scale sustainably.
Our Advisory Board
Other advisors (Discussion Ongoing)








